Xiaoying Ying
Impact in
- Pharmaceutical Science top 1%
- Advanced Drug Delivery Systems
- Advancements in Transdermal Drug Delivery
- Biomaterials top 1%
- Nanoparticle-Based Drug Delivery
Papers in
- Biomaterials 20
- Nanoparticle-Based Drug Delivery 19
-
- RNA Interference and Gene Delivery 5
- Lipid Membrane Structure and Behavior 5
- Co-authors
- Yongzhong Du (40 shared papers)Jing Qi (19 shared papers)Gaofeng Shu (15 shared papers)Xiaoling Xu (18 shared papers)Xu-Qi Kang (16 shared papers)Jian You (14 shared papers)Feiyang Jin (9 shared papers)Di Liu (9 shared papers)
In The Last Decade
Xiaoying Ying
70 papers receiving 3.3k citations
Xiaoying Ying's Hit Papers
Peers
Comparison fields: 5 of 120
- Pharmaceutical Science 417
- Biomaterials 840
- Nephrology 190
- Molecular Medicine 125
- Biomedical Engineering 886
Countries citing papers authored by Xiaoying Ying
This map shows the geographic impact of Xiaoying Ying's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoying Ying with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoying Ying more than expected).
Fields of papers citing papers by Xiaoying Ying
This network shows the impact of papers produced by Xiaoying Ying. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoying Ying. The network helps show where Xiaoying Ying may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaoying Ying, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 71 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | ROS-responsive nano-drug delivery system combining mitochondria-targeting ceria nanoparticles with atorvastatin for acute kidney injury Hit paper breakdown → | 2020 | 273 |
| 2 | 2020 | 171 | |
| 3 | 2014 | 143 | |
| 4 | 2015 | 134 | |
| 5 | 2014 | 127 | |
| 6 | 2019 | 118 | |
| 7 | 2021 | 110 | |
| 8 | 2011 | 95 | |
| 9 | 2019 | 92 | |
| 10 | 2018 | 83 | |
| 11 | 2018 | 69 | |
| 12 | 2017 | 67 | |
| 13 | 2007 | 67 | |
| 14 | 2017 | 66 | |
| 15 | 2018 | 65 | |
| 16 | 2019 | 64 | |
| 17 | 2009 | 62 | |
| 18 | 2019 | 61 | |
| 19 | 2019 | 60 | |
| 20 | 2016 | 56 |
About Xiaoying Ying
Xiaoying Ying is a scholar working on Biomaterials, Molecular Biology, Pharmaceutical Science, Biomedical Engineering and Oncology, having authored 71 papers that have together received 3.3k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (19 papers), Nanoplatforms for cancer theranostics (11 papers), Advancements in Transdermal Drug Delivery (8 papers), Advanced Drug Delivery Systems (8 papers), Rheumatoid Arthritis Research and Therapies (6 papers), RNA Interference and Gene Delivery (5 papers), Acute Kidney Injury Research (5 papers) and Lipid Membrane Structure and Behavior (5 papers). The work is most often cited by research in Pharmaceutical Science (417 citations), Biomaterials (840 citations), Nephrology (190 citations), Molecular Medicine (125 citations) and Biomedical Engineering (886 citations). Xiaoying Ying has collaborated with scholars based in China, Czechia and Japan. Frequent co-authors include Yongzhong Du, Jing Qi, Gaofeng Shu, Xiaoling Xu, Xu-Qi Kang, Jian You, Feiyang Jin, Di Liu, Saiping Jiang and Jiansong Ji. Their work appears in journals such as International Journal of Pharmaceutics, RSC Advances, Biomaterials, Journal of Controlled Release and Carbohydrate Polymers.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.